Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with insulin requiring type 1 or type 2 diabetes for at least 24 months~* Current treatment with human insulin (either premix of short and long/intermediate acting insulin) in a twice daily treatment regimen preparation and/or self-mix for at least 12 months~* Body mass index (BMI) below or equal to 35.0 kg/m\^2~* HbA1c below or equal to 11.0%~Exclusion Criteria:~* Total daily insulin dose at least 1.4 IU/kg~* Treatment with oral hypoglycaemic agents within the month prior to inclusion~* Recurrent severe hypoglycaemia (as judged by the investigator)~* Active proliferative retinopathy~* Impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)~* History of pancreatitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None
- B (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).